Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 8787-8793

  Sun, Dezhong ^a   Yang, Zhaoke ^a   Fu, Yugui ^a   Chen, Yanlin ^a   Wang, Shoufeng ^a   Zhang, Yun ^a   Ma, Yanyi ^a   Zhang, Xiaoyan ^a  

^a People's Hospital of Linyi City   (China)

Author keywords

Diagnosis; Meta analysis; Nasopharyngeal carcinoma; Serum Epstein Barr virus DNA

Indexed keywords

EPSTEIN BARR VIRUS DNA; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS DNA ASSAY; HUMAN; META ANALYSIS; NASOPHARYNX CARCINOMA; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; BLOOD; EPSTEIN-BARR VIRUS INFECTIONS; FEASIBILITY STUDY; GENETICS; HOST PATHOGEN INTERACTION; NASOPHARYNGEAL NEOPLASMS; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; VIROLOGY;

DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEASIBILITY STUDIES; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; NASOPHARYNGEAL NEOPLASMS; ROC CURVE;

EID: 84919874825     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2148-x     Document Type: Article

References (18)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
2. Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178.
3. Raab-Traub N, Flynn K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer. 1987;39:25–9.
4. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
5. Deville WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002;2:9.
6. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
7. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
8. Mutirangura A, Pornthanakasem W, Theamboonlers A, et al. Epstein–Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res. 1998;4:665–9.
9. Shotelersuk K, Khorprasert C, Sakdikul S, et al. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res. 2000;6:1046–51.
10. Chan KH, Gu YL, Ng F, et al. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer. 2003;105:706–9.
11. Fan H, Nicholls J, Chua D, et al. Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus. Int J Cancer. 2004;112:1036–41.
12. Krishna SM, James S, Kattoor J, et al. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin. Jpn J Clin Oncol. 2004;34:307–11.
13. Luo YL, Ou GP, Chi PD, et al. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma. Chin J China. 2009;28:96–9.
14. Mo WN, Tang AZ, Zhou L, et al. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+/CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen. Chin Med J (Engl). 2009;122:1173–8.
15. Tan YJ, Su XK, Cui JH. Comparison of detection of serum VCA-lgA, EA-IgA and EBV-DNA in nasopharyngeal carcinoma patient. Chongqing Med J. 2010;39:703–6.
16. Wei K, Xu Y, Liu J, Zhang W, Liang Z. No incidence trends and no change in pathological proportions of nasopharyngeal carcinoma in Zhongshan in 1970-2007. Asian Pac J Cancer Prev. 2010;11:1595–9.
17. Zhang LW, Luo BQ, Dou XQ, et al. Quantitative analysis of Epstein-Barr virus DNA in saliva, blood serum and peripheral blood cells in patients with nasopharyngeal carcinoma. Chin J Otorhinolaryngol Skull Base Surg. 2012;18:24–7.
18. Rosenfeld RM, Shiffman RN. Clinical practice guidelines: a manual for developing evidence-based guidelines to facilitate performance measurement and quality improvement. Otolaryngol Head Neck Surg. 2006;135:S1–28.